Prolonged activation of ERK2 by epidermal growth factor and other growth factors requires a functional insulin-like growth factor 1 receptor

Endocrinology

Volumn 140, Issue 7, 1999, Pages 3163-3169

  Swantek, Jennifer L ^a,b   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME ASSAY; GENE MUTATION; HOMOZYGOSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0033305195     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.7.6766     Document Type: Article

References (45)

1. Cell cycle and growth control
2. Cytokines and cell growth control
3. Biological actions of the insulin-like growth factors
4. The role of the IGF-1 receptor in the growth and transformation of mammalian cells
5. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-I (IGF-I) receptor are non-tumorigenic and induce regression of wild type tumors
6. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor
7. The insulin-like growth factor I receptor: A key to tumor growth?
8. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis
9. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and Type 1 IGF receptor (Igflr)
10. Role of insulin-like growth factors in embryonic and postnatal growth
11. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
12. The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen
13. A functional insulin-like growth factor I receptor is required for the mitogenic, and transforming activities of the epidermal growth factor receptor
14. Insulin-like growth factor I receptor is required for the mitrogenic and transforming activities of the platelet-derived growth factor receptor
15. Failure of the bovine papilloma-virus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes
16. Signal transduction by receptors with tyrosine kinase activity
17. IRS-1 is a common element in insulin and insulin-like growth factor-1 signaling to the phosphatidylinositol 3'-kinase
18. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: Implications for insulin control of ras signalling
19. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation
20. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras
21. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling
22. How receptors turn Ras on
23. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
24. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control
25. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
26. Activation of a rnicrotubule-associated protein-2 kinase by insulin-like growth factor-I in bovine chromaffin cells
27. MAP kinase by any other name smells just as sweet
28. ma(p)(k) are required for fibroblast proliferation
29. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
30. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells
31. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor
32. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-1 receptor
33. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts
34. Mitogen-activated protein kinase pathways
35. ma(p)(k) (ERK1) by growth factors: Correlation between late phase activation and mitogenicity
36. Differential activation of p44mapk (ERK1) by a-thrombin and thrombin-receptor peptide agonist
37. Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells
38. The β-PDGF receptor induces neuronal differentiation of PC12 cells
39. Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1, and the 90-kDa ribosomal S6 kinase in PC12 cells. Distinct effects of the neurotrophic factor, nerve growth factor, and the mitogenic factor, epidermal growth factor
40. Competitive binding of somatomedin to the insulin receptors of adipocytes, chondrocytes, and liver membranes
41. Characterization of the insulin and somatomedin-C receptors in human placental cell membranes
42. Roles of insulin-like growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells
43. Insulin-like growth factor receptors
44. Tumor promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654
45. Protein-tyrosine kinases